Should the €6.3 million effort prove successful, it could lead to the adoption of Volition's assay for routine clinical use across France.
Top Five Articles on 360Dx Last Week: Roche Vaginitis Test; FDA Reclassification of CDx Assays; More
Last week, readers were most interested in a story about a PCR test from Roche for vaginitis getting CE marking.
Jefferies analyst Tycho Peterson cited the large addressable market for the company's PreTRM blood test for assessing pregnant women's risk of preterm birth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback